Your browser doesn't support javascript.
loading
Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients.
Durango, Esteban; Dietrich, Christian; Seitz, Helmut Karl; Kunz, Cornelia Ursula; Pomier-Layrargues, Gilles T; Duarte-Rojo, Andres; Beaton, Melanie; Elkhashab, Magdy; Myers, Robert P; Mueller, Sebastian.
Afiliação
  • Durango E; Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, Germany.
  • Dietrich C; Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, Germany.
  • Seitz HK; Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, Germany.
  • Kunz CU; Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
  • Pomier-Layrargues GT; Liver Unit, Centre Hospitalier de l'Université de Montréal, Hôpital Saint-Luc, Montréal, Quebec, Canada.
  • Duarte-Rojo A; Toronto Western Hospital Liver Centre, Toronto, Ontario, Canada.
  • Beaton M; Multi-Organ Transplant Unit, University of Western Ontario, London, Ontario, Canada.
  • Elkhashab M; The Toronto Liver Centre, Toronto, Ontario, Canada.
  • Myers RP; Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Mueller S; Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, Germany ; Liver Unit, Centre Hospitalier de l'Université de Montréal, Hôpital Saint-Luc, Montréal, Quebec, Canada.
Hepat Med ; 5: 43-52, 2013.
Article em En | MEDLINE | ID: mdl-24696623
ABSTRACT

BACKGROUND:

A novel Fibroscan XL probe has recently been introduced and validated for obese patients, and has a diagnostic accuracy comparable with that of the standard M probe. The aim of this study was to analyze and understand the differences between these two probes in nonobese patients, to identify underlying causes for these differences, and to develop a practical algorithm to translate results for the XL probe to those for the M probe. METHODS AND

RESULTS:

Both probes were directly compared first in copolymer phantoms of varying stiffness (4.8, 11, and 40 kPa) and then in 371 obese and nonobese patients (body mass index, range 17.2-72.4) from German (n = 129) and Canadian (n = 242) centers. Liver stiffness values for both probes correlated better in phantoms than in patients (r = 0.98 versus 0.82, P < 0.001). Significantly more patients could be measured successfully using the XL probe than the M probe (98.4% versus 85.2%, respectively, P < 0.001) while the M probe produced a smaller interquartile range (21% versus 32%). Failure of the M probe to measure liver stiffness was not only observed in patients with a high body mass index and long skin-liver capsule distance but also in some nonobese patients (n = 10) due to quenching of the signal from subcutaneous fat tissue. In contrast with the phantoms, the XL probe consistently produced approximately 20% lower liver stiffness values in humans compared with the M probe. A long skin-liver capsule distance and a high degree of steatosis were responsible for this discordance. Adjustment of cutoff values for the XL probe (<5.5, 5.5-7, 7-10, and >10 kPa for F0, F1-2, F3, and F4 fibrosis, respectively) significantly improved agreement between the two probes from r = 0.655 to 0.679.

CONCLUSION:

Liver stiffness can be measured in significantly more obese and nonobese patients using the XL probe than the M probe. However, the XL probe is less accurate and adjusted cutoff values are required.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article